Abstract
China has the second highest caseload of multidrug-resistant tuberculosis (MDR-TB) in the world. In 2009, the Chinese government agreed to draw up a plan for MDR-TB prevention and control in the context of a comprehensive health system reform launched in the same year. China is facing high prevalence rates of drug-resistant TB and MDR-TB. MDR-TB disproportionally affects the poor rural population and the highest rates are in less developed regions largely due to interrupted and/or inappropriate TB treatment. Most households with an affected member suffer a heavy financial burden because of a combination of treatment and other related costs. The influential Global Fund programme for MDR-TB control in China provides technical and financial support for MDR-TB diagnosis and treatment. However, this programme has a fixed timeline and cannot provide a long term solution. In 2009, the Bill and Melinda Gates Foundation, in cooperation with the National Health and Family Planning Commission of China, started to develop innovative approaches to TB/MDR-TB management and case-based payment mechanisms for treatment, alongside increased health insurance benefits for patients, in order to contain medical costs and reduce financial barriers to...Continue Reading
References
Mar 21, 2006·Lancet·Mario C Raviglione, Mukund W Uplekar
Aug 31, 2006·Health Policy and Planning·B XuL Bogg
Apr 17, 2007·Health Policy and Planning·Knut LönnrothMukund Uplekar
Dec 14, 2007·Tropical Medicine & International Health : TM & IH·Xiaoyun LiuShenglan Tang
Apr 22, 2009·Lancet·Margaret Harris Cheng
Nov 18, 2009·Tropical Medicine & International Health : TM & IH·Qin LiuPaul Garner
May 22, 2010·Lancet·Knut LönnrothMario C Raviglione
Jun 24, 2010·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Xiao-Yan YangSi-Miao Wu
Sep 10, 2010·The New England Journal of Medicine·Eva NathansonMario Raviglione
Nov 3, 2010·Journal of Health Economics·Christoph M Schmidt, Harald Tauchmann
Nov 5, 2010·The New England Journal of Medicine·Salmaan Keshavjee, Paul E Farmer
May 28, 2011·BMC Public Health·Qian LongPaul Garner
Oct 18, 2011·Emerging Infectious Diseases·Guang Xue HeSusan van den Hof
Mar 6, 2012·Lancet·Winnie Chi-Man YipAlan Maynard
Mar 10, 2012·Thorax·Libo LiangLiyuan Han
Jun 8, 2012·The New England Journal of Medicine·Yanlin ZhaoYu Wang
Nov 10, 2012·PLoS Medicine·David HipgraveHana Brixi
Feb 22, 2013·BMC Infectious Diseases·Xiaolin WeiQiang Sun
Mar 28, 2013·The Lancet Infectious Diseases·Ibrahim AbubakarAlimuddin Zumla
Jul 24, 2013·The International Journal of Health Planning and Management·Shenglan TangHenk Bekedam
Dec 19, 2013·TheScientificWorldJournal
Mar 22, 2015·The Lancet Global Health·Renzhong LiDaniel P Chin
Citations
Jan 30, 2016·Infectious Diseases of Poverty·Shenglan TangDaniel P Chin
Oct 21, 2017·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hai HuangHui Gan
Sep 12, 2018·Global Health Action·Zhiqi YangBiao Xu
Jul 13, 2019·Tropical Medicine & International Health : TM & IH·Wenhui MaoShenglan Tang
Nov 20, 2019·PLoS Medicine·Shu ChenShenglan Tang
Jun 19, 2019·Emerging Infectious Diseases·Fei HuangFrank Cobelens
Feb 27, 2020·International Journal of Environmental Research and Public Health·Qian LongShenglan Tang
Feb 12, 2020·BMC Infectious Diseases·Abela Mpobela AgnarsonLaurent Metz
Nov 4, 2017·Scientific Reports·Sui ZhuJuying Zhang
Aug 3, 2019·Infectious Diseases of Poverty·Yan-Jiao XinFei Huang
Aug 15, 2020·Medicine·Qingchun LiHan-Zhu Qian
Jul 20, 2020·Infectious Diseases of Poverty·Xu-Bin ZhengBiao Xu
Apr 13, 2018·BMC Health Services Research·Sucitro Dwijayana SidhartaMishal Sameer Khan
Dec 11, 2019·PloS One·Bo WuDaiyu Hu
Jan 21, 2021·Infectious Diseases of Poverty·Xiao-Yan DingLi-Mei Zhu
Nov 12, 2020·Risk Management and Healthcare Policy·Peize ZhangGuofang Deng
Dec 3, 2020·Patient Preference and Adherence·Liang DuLing Zhou
Oct 30, 2020·Infection and Drug Resistance·Yuou ZhangJing Sun
Feb 26, 2021·Infectious Diseases of Poverty·Ye-Sheng WangWei-Bing Wang
Mar 20, 2021·Scientific Reports·Siyu BieZhihui Dou
Apr 14, 2021·BMJ Open·Weixi JiangFrank Cobelens
Apr 23, 2021·Infectious Diseases of Poverty·Wei-Xi JiangSheng-Lan Tang
Jun 10, 2020·Infectious Diseases of Poverty·Bing-Ying LiBiao Xu
Aug 14, 2021·Infectious Diseases of Poverty·Bin ChenBiao Xu